Dermapharm Holding SE (ETR: DMP)

Dermapharm Holding SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,174	1,150	1,040	959.6	807.64	713.51
Other Revenue	0.42	0.42	0.25	0.49	0.67	0.87
Revenue	1,174	1,151	1,041	960.09	808.31	714.38
Revenue Growth (YoY)	0.17%	10.59%	8.38%	18.78%	13.15%	22.30%
Cost of Revenue	439.61	446.6	391.85	349.87	354.42	336.99
Gross Profit	734.32	704.14	648.7	610.22	453.89	377.38
Selling, General & Admin	282.77	271.01	190.56	168.95	158.06	115.92
Other Operating Expenses	154.09	151.21	117.72	99.68	110.13	93.28
Operating Expenses	519.91	510.99	365.98	314.31	313.77	256.94
Operating Income	214.41	193.16	282.72	295.91	140.12	120.44
Interest Expense	-58.01	-54.97	-12.34	-8.84	-9.36	-10.07
Interest & Investment Income	9.91	2.49	0.33	4.02	0.51	2.06
Earnings From Equity Investments	1.04	-7.16	-13.54	0.32	-1.5	-1.11
Currency Exchange Gain (Loss)	-1.95	-1.95	0.37	2.28	-1.63	-0.92
Other Non Operating Income (Expenses)	-14.69	-16.63	-1.12	-0.83	0.24	0.09
EBT Excluding Unusual Items	150.7	114.93	256.43	292.86	128.38	110.49
Merger & Restructuring Charges	-	-	-	-0.6	-	-
Impairment of Goodwill	-	-	-36.45	-5.43	-	-
Gain (Loss) on Sale of Investments	-1.98	-1.98	-	9.06	-	-
Gain (Loss) on Sale of Assets	2.96	2.96	3.13	1.38	0.23	-0
Asset Writedown	-15.82	-15.82	-7.03	-4.48	-3.58	-2.39
Other Unusual Items	5.78	5.78	-	-	-	1.48
Pretax Income	141.76	106	216.3	292.98	125.28	110.07
Income Tax Expense	52.44	45.46	83.68	84.07	39.36	32.25
Earnings From Continuing Operations	89.32	60.53	132.62	208.9	85.93	77.81
Minority Interest in Earnings	1.26	1.83	1.62	0.68	-0.1	-0.62
Net Income	90.59	62.37	134.24	209.58	85.83	77.2
Net Income to Common	90.59	62.37	134.24	209.58	85.83	77.2
Net Income Growth	-4.60%	-53.54%	-35.95%	144.20%	11.18%	2.49%
Shares Outstanding (Basic)	54	54	54	54	54	54
Shares Outstanding (Diluted)	54	54	54	54	54	54
Shares Change (YoY)	0.23%	-	-	-	-	0.79%
EPS (Basic)	1.68	1.16	2.49	3.89	1.59	1.43
EPS (Diluted)	1.68	1.16	2.49	3.89	1.59	1.43
EPS Growth	-4.82%	-53.54%	-35.91%	144.65%	11.19%	1.42%
Free Cash Flow	157.1	177.88	249.52	189.17	90.3	54.17
Free Cash Flow Per Share	2.91	3.30	4.63	3.51	1.68	1.01
Dividend Per Share	0.880	0.880	1.050	2.170	0.880	0.800
Dividend Growth	-16.19%	-16.19%	-51.61%	146.59%	10.00%	3.90%
Gross Margin	62.55%	61.19%	62.34%	63.56%	56.15%	52.83%
Operating Margin	18.26%	16.79%	27.17%	30.82%	17.34%	16.86%
Profit Margin	7.72%	5.42%	12.90%	21.83%	10.62%	10.81%
Free Cash Flow Margin	13.38%	15.46%	23.98%	19.70%	11.17%	7.58%
EBITDA	234.73	220.31	302.36	312.36	155.05	130.9
EBITDA Margin	19.99%	19.14%	29.06%	32.53%	19.18%	18.32%
D&A For EBITDA	20.32	27.15	19.64	16.45	14.92	10.45
EBIT	214.41	193.16	282.72	295.91	140.12	120.44
EBIT Margin	18.26%	16.79%	27.17%	30.82%	17.34%	16.86%
Effective Tax Rate	36.99%	42.89%	38.69%	28.70%	31.41%	29.30%

Source: S&P Capital IQ. Standard template. Financial Sources.